Literature DB >> 11159548

CTLA-4 blockade of antigen-induced cell death.

S da Rocha Dias1, C E Rudd.   

Abstract

While cytotoxic T lymphocyte antigen-4 (CTLA-4) negatively regulates T-cell receptor (TCR)-driven interleukin (IL)-2 production and proliferation, little is known regarding whether the coreceptor has the capacity to inhibit other events, such as Fas ligand (FasL) expression and antigen-induced cell death (AICD). In this study, it is shown that CTLA-4 expressed in a T-cell hybridoma can elicit a potent block of FasL expression and AICD. Inhibition occurred independently of CTLA-4 blockage of IL-2 production and was partially reversed by a single mutation in the cytoplasmic YVKM motif. These findings indicate that CTLA-4 can block TCR signaling prior to bifurcation of signals leading to IL-2 production and apoptosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11159548     DOI: 10.1182/blood.v97.4.1134

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  16 in total

Review 1.  Challenges and opportunities in targeting the CD28/CTLA-4 pathway in transplantation and autoimmunity.

Authors:  Rebecca L Crepeau; Mandy L Ford
Journal:  Expert Opin Biol Ther       Date:  2017-05-30       Impact factor: 4.388

2.  Blockade of CTLA-4 on CD4+CD25+ regulatory T cells abrogates their function in vivo.

Authors:  Simon Read; Rebecca Greenwald; Ana Izcue; Nicholas Robinson; Didier Mandelbrot; Loise Francisco; Arlene H Sharpe; Fiona Powrie
Journal:  J Immunol       Date:  2006-10-01       Impact factor: 5.422

3.  Lack of intrinsic CTLA-4 expression has minimal effect on regulation of antiviral T-cell immunity.

Authors:  Dirk Homann; Wolfgang Dummer; Tom Wolfe; Evelyn Rodrigo; Argyrios N Theofilopoulos; Michael B A Oldstone; Matthias G von Herrath
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

4.  Regulation of the small GTPase Rap1 and extracellular signal-regulated kinases by the costimulatory molecule CTLA-4.

Authors:  Tara J Dillon; Kendall D Carey; Scott A Wetzel; David C Parker; Philip J S Stork
Journal:  Mol Cell Biol       Date:  2005-05       Impact factor: 4.272

5.  Role of activation-induced cell death in pathogenesis of patients with chronic hepatitis B.

Authors:  Chun-Sheng Hou; Gui-Qiang Wang; Shu-Lan Lu; Bei Yue; Ming-Rong Li; Xiao-Yan Wang; Jian-Wu Yu
Journal:  World J Gastroenterol       Date:  2003-10       Impact factor: 5.742

6.  Differential expression of CTLA-4 among T cell subsets.

Authors:  C B Jago; J Yates; N Olsen Saraiva Câmara; R I Lechler; G Lombardi
Journal:  Clin Exp Immunol       Date:  2004-06       Impact factor: 4.330

7.  Cutting Edge: Skin CCR10+ CD8+ T Cells Support Resident Regulatory T Cells through the B7.2/Receptor Axis To Regulate Local Immune Homeostasis and Response.

Authors:  Yaoyao Fu; Jie Yang; Na Xiong
Journal:  J Immunol       Date:  2016-05-09       Impact factor: 5.422

8.  CTLA-4 disrupts ZAP70 microcluster formation with reduced T cell/APC dwell times and calcium mobilization.

Authors:  Helga Schneider; Xin Smith; Hebin Liu; Georges Bismuth; Christopher E Rudd
Journal:  Eur J Immunol       Date:  2008-01       Impact factor: 5.532

Review 9.  Treatment of allergic asthma: modulation of Th2 cells and their responses.

Authors:  Berislav Bosnjak; Barbara Stelzmueller; Klaus J Erb; Michelle M Epstein
Journal:  Respir Res       Date:  2011-08-25

10.  CTLA-4-Tg/CD-28-KO Mice Exhibit Reduced T Cell Proliferation in vivo Compared to CD-28-KO Mice in a Graft-versus-host Disease Model.

Authors:  Jong-Sun Yoo; Yun-Jung Lee; Joo Won Yoon; Kyeong Eun Hyung; Kwang Woo Hwang
Journal:  Korean J Physiol Pharmacol       Date:  2012-10-18       Impact factor: 2.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.